VPM1002

VPM1002 is a new type of TB vaccine designed to protect people from tuberculosis, a serious bacterial infection. It uses a safe version of the bacteria to train the immune system to recognize and fight the disease more effectively. Unlike traditional vaccines, VPM1002 also stimulates longer-lasting immunity and may offer better protection, especially in areas with high TB rates. It is designed to be safe for adults, children, and vulnerable groups, and has undergone various clinical trials to ensure its effectiveness and safety. Overall, VPM1002 aims to improve tuberculosis prevention worldwide.